Skip to content

Peri-Strips Dry (PSD) Veritas Collagen Matrix Staple Line Reinforcement for Colorectal Surgery

Peri-Strips Dry With Veritas Collagen Matrix Staple Line Reinforcement for Colorectal Surgery

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00559013
Enrollment
38
Registered
2007-11-16
Start date
2007-03-31
Completion date
2008-12-31
Last updated
2017-05-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal Cancer

Keywords

Staple line reinforcement, Staple line buttress, Anastomotic reinforcement

Brief summary

Purpose of the study is to assess the utility of PSD Veritas as a staple line reinforcement to minimize the risk of leakage during or after colo-rectal surgery.

Detailed description

Study is designed as a prospective enrollment of patients undergoing open or laparoscopic colorectal surgery requiring the creation of an anastomosis. Patients who are scheduled for elective resection of the left, anterior and low anterior colon can be enrolled in the study.

Interventions

Placement of reinforcement material on circular anastomotic staple line for prevention of leak during and post surgery.

Sponsors

Synovis Surgical Innovations
CollaboratorINDUSTRY
Baxter Healthcare Corporation
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patient must comply with follow-up evaluations * Patient or representative must provide informed consent prior to enrollment * Patient scheduled for elective surgical excision of the left, anterior or low anterior colon * Patient must meet all criteria and be eligible to have open or laparoscopic colorectal surgery with primary anastomosis at one location

Exclusion criteria

* Crohns disease * Emergency colorectal surgery for trauma, obstruction, ischemic bowel, perforated diverticulum and all other emergent diagnosis. * Patients who have not had mechanical bowel preparation * Patients with known documented sensitivity/allergy to bovine material * Severe radiation damage to tissue * Carcinomatosis or stage IV cancer * BMI is 35 or greater * Cancer at primary anastomosis site that cannot be excised * Patients who require an ileo rectal anastomosis * Surgery anticipated to include jejunostomy pouch * Anticipated diverting stoma * No anti adhesive barrier can be used around anastomotic site * No multiple circular anastomosis * Surgeons discretion to exclude any patient he/she feels would not have a safe anastomosis * Patient life expectacny less than follow-up timeframe of study * Pregnancy * Patients currently enrolled in a study that competes for the same patient population

Design outcomes

Primary

MeasureTime frame
Number of Participants With Major Colorectal Related Adverse Events: Leak, Stricture and Hemorrhage.Discharge and 1 Month post surgery

Countries

United States

Participant flow

Recruitment details

38 subjects were recruited from two principal investigators and their respective surgical hospitals in the US from approximately February 2007 through October 2008.

Pre-assignment details

Subjects were excluded from the study if the met any of the exclusion criteria including having a a body mass index greater than 35, a history of Chron's Disease, or stage IV cancer. There was no washout, run-in or transition period to this study.

Participants by arm

ArmCount
PSD Veritas Collagen Matrix Reinforcement Arm
Subjects receiving PSD Veritas Collagen Matrix for staple line reinforcement when undergoing open or laparoscopic colorectal surgery requiring the creation of an anastomosis.
38
Total38

Baseline characteristics

CharacteristicPSD Veritas Collagen Matrix Reinforcement Arm
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
11 Participants
Age, Categorical
Between 18 and 65 years
27 Participants
Age, Continuous57.26 years
STANDARD_DEVIATION 11.44
Region of Enrollment
United States
38 participants
Sex: Female, Male
Female
18 Participants
Sex: Female, Male
Male
20 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
— / —
other
Total, other adverse events
2 / 38
serious
Total, serious adverse events
3 / 38

Outcome results

Primary

Number of Participants With Major Colorectal Related Adverse Events: Leak, Stricture and Hemorrhage.

Time frame: Discharge and 1 Month post surgery

ArmMeasureValue (NUMBER)
PSD Veritas Collagen Matrix Reinforcement ArmNumber of Participants With Major Colorectal Related Adverse Events: Leak, Stricture and Hemorrhage.4 Participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026